TABLE 1.

Responses from Fig. 1, measured as peak current and net charge (Papke and Porter Papke, 2002) relative to the average of two initial ACh control responses (Materials and Methods)

Drugs applied	n	Peak current	Net charge
A. 30 µM ACh	8	0.43 ± 0.03	0.69 ± 0.03
B. 30 µM ACh + 10 µM PNU-120596	4	14.8 ± 9.9	32.3 ± 5.8
C. 10 µM GAT107	5	31.7 ± 7.8	63.3 ± 14.1
D. 30 µM ACh + 10 µM GAT107	4	33.6 ± 24.4	96.22 ± 27.7
E. 10 µM B-973B	6	2.24 ± 0.92	29.0 ± 6.4
F. 30 µM ACh + 10 µM B-973B	6	19.5 ± 7.5	257 ± 131
G. 30 µM ACh + 10 µM TQS	5	6.6 ± 1.0	27.1 ± 6.3